Nepal signs deal for 2m Bangladeshi coronavirus vaccine
Staff Correspondent || shiningbd
Neighboring Nepal has signed a deal with Bangladeshi firm Globe Biotech Pharmaceuticals to buy 2 million doses of it’s coronavirus vaccine ‘BANCOVID’ before its clinical trial.
"Orders of some 20 million doses of the vaccine are in pipeline," Harunur Rashid, Chairman of Globe Biotech came up with the announcement during a media briefing on Thursday.
Globe's vaccine was listed on the World Health Organisation (WHO) draft landscape of Covid-19 candidate vaccines on October 15.
Meanwhile, the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) is going to hold a human trial of BANCOVID soon.
On 2 July, Globe Biotech announced they were developing a Covid-19 vaccine as they had completed preliminary animal trials successfully.
On October 5, they said they had received "very promising" results from the pre-clinical trials on rabbits and mice.
The company said BANCOVID would hit the market in late December or early January next year if the government was fully supportive.